학술논문

Once-weekly insulin icodec versus once-daily insulin degludec as part of a basal-bolus regimen in individuals with type 1 diabetes (ONWARDS 6): a phase 3a, randomised, open-label, treat-to-target trial
Document Type
Article
Source
In: The Lancet. (The Lancet, 4 November 2023, 402(10413):1636-1647)
Subject
Language
English
ISSN
1474547X
01406736